Overview

Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment

Status:
Completed
Trial end date:
2009-06-12
Target enrollment:
Participant gender:
Summary
This clinical trial program was established according to the ethical principles of the Helsinki declaration and the GCP guiding principle, and a randomized grouping method was used to evaluate the efficacy and safety of Compound Methyl Salicylate Liniment in the treatment of acute and chronic soft tissue pain with a positive control drug, named Diclofenac Sodium Liniment.
Phase:
N/A
Details
Lead Sponsor:
Peking University People's Hospital
Treatments:
Diclofenac
Methyl salicylate
Salicylates
Salicylic Acid